Login to Your Account



Drugs for Algernon

Prenatal therapy normalizes Down syndrome mouse brains

By John Fox
Staff Writer

Wednesday, September 13, 2017

Japanese researchers have identified a potent novel enhancer of neural stem cells (NSCs) and, hence, neurogenesis, with its prenatal administration having been shown to normalize both brain structure and function in mouse models of Down syndrome.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription